Diamant Asset Management »

Bridgebio Pharma shares owned by Diamant Asset Management

Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by Diamant Asset Management from 13F filings

Historical chart of Diamant Asset Management investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Diamant Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Diamant Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $527M 527k 1000.00

More positions owned by Diamant Asset Management

Apple (AAPL)
Alphabet Inc Class A cs (GOOGL)
Visa (V)
Microsoft Corporation (MSFT)
Costco Wholesale Corporation (COST)
Johnson & Johnson (JNJ)
Leidos Holdings (LDOS)
Progressive Corporation (PGR)
Lincoln Electric Holdings (LECO)
TJX Companies (TJX)
Abbvie (ABBV)
Pepsi (PEP)
Caterpillar (CAT)
McDonald's Corporation (MCD)
Colgate-Palmolive Company (CL)

View all positions for Diamant Asset Management

Top funds holding Bridgebio Pharma

Vanguard Group
BlackRock
Kohlberg Kravis Roberts & Co
Henderson Group
Viking Global Investors
Farallon Capital Management
Vanguard Portfolio Management
Vanguard Capital Management
UBS Group
Aisling Capital Management
State Street Corporation
Jane Street
Geode Capital Management
Invesco
Susquehanna International

View all funds holding Bridgebio Pharma